← Eichor
Study identifier: NCT06305182 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Metreleptin in Anorexia Nervosa

Condition: Anorexia Nervosa  ·  Sponsor: Gabriella Milos

PhasePhase 2
Planned participants50
Who can joinAll sexes, 17 Years to 65 Years
Healthy volunteersNo

About this study

The treatment of anorexia nervosa often proves to be difficult. There are no drugs that work specifically for the treatment of anorexia nervosa. Experimental administration of metreleptin (synthetically produced leptin) to patients with anorexia nervosa has produced positive results. This study tests the effect of metreleptin in comparison with placebo, which could potentially make treatment easier. The aim of the study is to investigate whether treatment with metreleptin can help to reduce the symptoms of anorexia nervosa and improve mood and weight.

This description comes directly from the study's public registry record.

Talk to the study team

Gabriella Milos, Prof. Dr. med.  ·  0041 44 255 52 80  ·  Gabriella.Milos@usz.ch

Lisa Guth, MSc Psychology  ·  0041 44 255 97 17  ·  Lisa.Guth@usz.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Eating Disorder Unit, Clinic of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital ZurichZurich, Canton of Zurich, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06305182